FindTrial
Sign In

Radioiodine

DRUG8 trials

Sponsors

University Hospital, Basel, Switzerland, Hospital de Clinicas de Porto Alegre, Boston Children's Hospital, University of Pisa, Taichung Veterans General Hospital

Conditions

Differentiated thyroid carcinoma thyroid cancerGraves DiseaseHyperthyroidismPapillary Thyroid CancerThyroid CancerThyroid DiseasesXerostomia

Phase 3

Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism
CompletedNCT01039818
Hospital de Clinicas de Porto AlegreGraves Disease
Start: 1997-02-28End: 2011-08-31Updated: 2012-09-06

Unknown Phase

Dental Safety Profile of High-Dose Radioiodine Therapy
CompletedNCT00439478
University Hospital, Basel, SwitzerlandThyroid Cancer
Start: 2004-09-30End: 2006-09-30Target: 202Updated: 2007-11-14
Effect of Childhood Radioiodine Therapy on Salivary Function
CompletedNCT02375451
Boston Children's HospitalHyperthyroidism, Thyroid Cancer, Xerostomia
Start: 2014-09-30End: 2016-09-30Updated: 2017-06-26
Low-dose Radioiodine Ablation in Graves' Disease
CompletedNCT03110835
University of PisaThyroid Diseases
Start: 2016-01-01End: 2017-03-28Updated: 2017-04-12
Male fertility after treatment with radioiodine for differentiated thyroid carcinoma
Active, not recruitingNL-OMON45710
Universitair Medisch Centrum GroningenDifferentiated thyroid carcinoma thyroid cancer
Start: 2017-09-05Target: 100Updated: 2024-02-28
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
Active, not recruitingNCT03624751
Taichung Veterans General HospitalThyroid Cancer
Start: 2018-06-06End: 2030-06-30Target: 107Updated: 2026-05-01
Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma
RecruitingNCT04354324
Zhujiang HospitalPapillary Thyroid Cancer
Start: 2020-04-20End: 2024-06-30Target: 254Updated: 2024-03-15
Salivary dysfuncTion After Radioiodine Treatment
CompletedNCT04876287
Institut de Radioprotection et de Surete NucleaireThyroid Cancer
Start: 2020-09-02End: 2021-04-26Updated: 2021-05-10

Related Papers

Recombinant Human Thyrotropin Reducing Insulin Resistance in Patients with Differentiated Thyroid Cancer
Journal of the Endocrine Society2026-09-03
Dysfunction of the Salivary and Lacrimal Glands After Radioiodine Therapy for Thyroid Cancer: Results of the START Study After 6-Months of Follow-Up
Thyroid2023-06-1015 citations
Salivary Dysfunctions and Consequences After Radioiodine Treatment for Thyroid Cancer: Protocol for a Self-Controlled Study (START Study)
JMIR Research Protocols2022-07-228 citations
Increasing the radioiodine dose does not improve cure rates in severe graves' hyperthyroidism: a clinical trial with historical control.
2013-07-318 citations